Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1999
11/20/1999CA2238289A1 Biocontrol agent and fungicide for blackleg disease
11/20/1999CA2238137A1 A universal plant promoter inducing gene transcription in response to low-temperatures
11/19/1999CA2270409A1 Novel mutations relating to x-linked charcot-marie-tooth disease
11/19/1999CA2237915A1 Osteoporosis treatment
11/18/1999WO1999059037A1 Methods of determining protein activity levels using gene expression profiles
11/18/1999WO1999058981A2 Diagnostic tests for alzheimer's disease
11/18/1999WO1999058980A1 HUMAN CHROMOGRANIN A (GgA) IMMUNOLOGIC ASSAY, ANTIBODIES, REAGENTS AND KITS FOR SAID ASSAY
11/18/1999WO1999058978A2 Tumour markers
11/18/1999WO1999058714A2 Method for screening for inhibitors and activators of type iii secretion machinery in gram-negative bacteria
11/18/1999WO1999058705A1 Recombinant baculovirus-based insecticides
11/18/1999WO1999058699A2 Transgenic plant-derived human blood coagulation factors
11/18/1999WO1999058695A1 USE OF A POLYPEPTIDE DERIVED FROM A PA1b LEGUME ALBUMEN AS INSECTICIDE
11/18/1999WO1999058693A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages
11/18/1999WO1999058692A2 Human apoptosis associated proteins
11/18/1999WO1999058687A2 Bacillus thuringiensis toxins and genes for controlling coleopteran pests
11/18/1999WO1999058685A2 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
11/18/1999WO1999058684A2 Compounds from moraxella catarrhalis
11/18/1999WO1999058683A2 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
11/18/1999WO1999058682A2 Compounds from moraxella catarrhalis
11/18/1999WO1999058681A2 Transgenic plant cells expressing a recombinant plant e2f peptide
11/18/1999WO1999058678A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
11/18/1999WO1999058677A1 Raq genes and their uses
11/18/1999WO1999058676A2 Semaphorin polypeptides
11/18/1999WO1999058675A2 Human genes and gene expression products v
11/18/1999WO1999058674A2 Method of inhibiting osteoclast activity
11/18/1999WO1999058673A1 Geminin genes and proteins
11/18/1999WO1999058672A1 Human promonocyte associated protein: prmnc
11/18/1999WO1999058671A2 Human and nematode homologues of the yeast longevity assurance gene lag1
11/18/1999WO1999058670A1 Ags proteins and nucleic acid molecules and uses therefor
11/18/1999WO1999058669A1 Rhoh genes and their uses
11/18/1999WO1999058668A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
11/18/1999WO1999058667A1 Rhotekin, a putative target for rho
11/18/1999WO1999058666A1 Potassium channel subunit
11/18/1999WO1999058665A2 Isolation and use of fetal urogenital sinus expressed sequences
11/18/1999WO1999058663A1 METHODS AND COMPOSITIONS FOR SCREENING FOR MODULATORS OF IgE SYNTHESIS, SECRETION AND SWITCH REARRANGEMENT
11/18/1999WO1999058662A1 Fused protein
11/18/1999WO1999058660A1 97 human secreted proteins
11/18/1999WO1999058659A2 Methods and compositions for expression of transgenes in plants
11/18/1999WO1999058658A2 Expression vectors for stimulating an immune response and methods of using the same
11/18/1999WO1999058657A2 Zea mays phosphate transporter genes and uses thereof
11/18/1999WO1999058654A2 Transgenic plants with a modified activity of a plastidial adp/atp translocator
11/18/1999WO1999058653A2 Method for producing plants having an increased tolerance against drought and/or fungal attack and/or increased salt concentrations and/or extreme temperature by the expression of plasmodesmata-localized proteins
11/18/1999WO1999058644A1 Compositions and methods for genetic transformation of pineapple
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058641A2 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999WO1999058640A2 Mct-1, a human oncogene
11/18/1999WO1999058639A2 Structural proteins of fish pancreatic disease virus and uses thereof
11/18/1999WO1999058638A2 Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
11/18/1999WO1999058573A1 Diagnosis and treatment of hepatic disorders
11/18/1999WO1999058571A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/18/1999WO1999058569A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS)
11/18/1999WO1999058568A1 Gprw receptor
11/18/1999WO1999058567A1 GABAB1b RECEPTOR
11/18/1999WO1999058566A1 INHIBITION OF p53 FUNCTION BY A p53-DERIVED SUBSTANCE
11/18/1999WO1999058565A1 Cystatin-related protein
11/18/1999WO1999058564A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999WO1999058563A2 Moraxella catharralis proteins
11/18/1999WO1999058562A2 Novel compounds
11/18/1999WO1999058561A1 Hepatitis c virus mimotopes
11/18/1999WO1999058560A2 Prostapin gene and protein and uses thereof
11/18/1999WO1999058559A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity
11/18/1999WO1999058558A2 Cell signaling proteins
11/18/1999WO1999058557A2 Dimers of the hla-b27 heavy chain extracellular domain and uses thereof
11/18/1999WO1999058556A2 Protein associated to hereditary spastic paraplegia
11/18/1999WO1999058552A2 Peptides that ellicit t, cellular immunity
11/18/1999WO1999058548A1 Mmsc2 - an mmaci interacting protein
11/18/1999WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
11/18/1999WO1999058147A1 APOPTOSIS OF NAIVE HUMAN NK CELLS BY CROSSLINKING OF THEIR FcγRIIIa MOLECULES WIHT A RAT IgG2b (LO-CD2a/BTI-322) OR ITS IgG1 HUMANIZED MONOCLONAL ANTIBODY
11/18/1999WO1999058146A1 ATTENUATED MUTANTS OF SALMONELLA WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN
11/18/1999WO1999058142A1 Use of anti-prolactin agents to treat proliferative conditions
11/18/1999WO1999058135A1 Compositions for the treatment of tumors, and uses thereof
11/18/1999WO1999058098A2 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
11/18/1999WO1999058097A2 Use of anti-prolactin agents to treat proliferative conditions
11/18/1999WO1999057956A2 Transcription factor regulating fgf-2 and variants thereof
11/18/1999WO1999051740A3 Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid, use for the regulation of fatty acids metabolism
11/18/1999WO1999051728A3 Control of floral induction in plants and uses therefor
11/18/1999WO1999051636A3 Gaba b receptor
11/18/1999WO1999050419A3 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
11/18/1999WO1999050406A3 Growth differentiation factor-9 regulatory sequences and uses therefor
11/18/1999WO1999050295A3 Agouti-related protein analogs and methods of use
11/18/1999WO1999050287A3 P40 protein acts as an oncogene
11/18/1999WO1999050286A3 Antioxidant peptides derived from apolipoprotein a-iv
11/18/1999WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999WO1999048915A9 Orphan nuclear receptor
11/18/1999WO1999047683A9 Gene encoding labyrinthin, a marker for cancer
11/18/1999WO1999047673A3 Isolated mammalian membrane protein genes and related reagents
11/18/1999WO1999047557A3 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins
11/18/1999WO1999047552A3 Genes encoding mlo proteins and conferring fungal resistance upon plants
11/18/1999WO1999046364A9 Vascular endothelial growth factor 2
11/18/1999WO1999046284A9 Molecules that home to various selected organs or tissues
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999046278A9 Viral vector directed to predetermined target cells
11/18/1999WO1999045962A9 Transgenic non-human animals capable of producing heterologous antibodies
11/18/1999WO1999045949A3 Use of follistatin to modulate gdf-8 and bmp-11
11/18/1999WO1999043834A3 P-selectin ligand protein, including tetrameric fusion proteins
11/18/1999WO1999042584A9 Apoptosis inducing molecule ii and methods of use
11/18/1999WO1999042571A8 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1
11/18/1999WO1999042076A9 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/18/1999WO1999038985A3 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
1 ... 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 ... 2916